SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 37 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | +25.0% | 897 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 897 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -93.2% | 897 | -40.8% | 0.00% | – |
| Q2 2020 | $44,000 | +300.0% | 1,514 | +177.8% | 0.00% | – |
| Q1 2020 | $11,000 | -38.9% | 545 | -40.1% | 0.00% | – |
| Q4 2019 | $18,000 | – | 910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 659,252 | $12,974,000 | 12.51% |
| RA Capital Management | 4,681,858 | $92,139,000 | 2.79% |
| Cormorant Asset Management, LP | 858,382 | $16,893,000 | 0.67% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $37,115,000 | 0.55% |
| Eventide Asset Management | 425,000 | $8,364,000 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 693,625 | $13,651,000 | 0.03% |
| Zimmer Partners, LP | 100,000 | $1,968,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,341,211 | $45,657,000 | 0.01% |
| Citadel Advisors | 1,017,482 | $20,024,000 | 0.01% |
| CREDIT SUISSE AG/ | 53,970 | $1,062,000 | 0.00% |